Amex Pharmacy (Pacifico National Inc.), Melbourne, FL
Is Amex Pharmacy (Pacifico National Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility, with FDA’s note “De-registered as an Outsourcing Facility”.
Does Amex Pharmacy (Pacifico National Inc.) hold a Florida pharmacy license?
The Florida Board of Pharmacy lists 2 licenses for this name and city, as of Nov 15, 2026: PH16954 for PACIFICO NATIONAL, INC (dba AMEX PHARMACY), MELBOURNE, status Closed and PH27532 for PACIFICO NATIONAL INC (dba Amex Pharmacy), MELBOURNE, status Closed. The Colorado State Board of Pharmacy also lists nonresident license OSP 5907 for Pacifico National Inc, Melbourne, FL, status Expired, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054016601 for PACIFICO NATIONAL INC (dba AMEX PHARMACY), MELBOURNE, FL, status CLOSED, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0003497 for PACIFICO NATIONAL INC (dba AMEX PHARMACY), MELBOURNE, FL, status INACTIVE, as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0001042 for Pacifico National, Inc. d/b/a/ Amex Pharmacy, MELBOURNE, FL, status Closed and license AA-0000029 for Pacifico National, Inc. d/b/a/ Amex Pharmacy, MELBOURNE, FL, status Expired, as of Nov 10, 2026.
Has Amex Pharmacy (Pacifico National Inc.) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Mar 10, 2021) and 2 FMD-145 letters (May 28, 2020 and Mar 10, 2021) for Amex Pharmacy (Pacifico National Inc.). State board actions: record found. The Florida Board of Pharmacy’s enforcement list for pharmacy permits lists 2 actions: “Probation Satisfied” dated Feb 22, 2017, case 201506647 on license PH27532 and “Administrative Complaint Filed” dated Mar 21, 2016, case 201506647 on license PH27532. The Colorado State Board of Pharmacy’s license dataset also lists 7 actions: “CLS Letter of Admonition” dated Jun 29, 2021, case 2021-1448 on nonresident license OSP 5907, “CLS Letter of Admonition” dated Apr 22, 2021, case 2021-5 on nonresident license OSP 5907 and “CLS Stipulation” dated Jun 16, 2020, case 2020-1439 on nonresident license OSP 5907, and more listed below. The Illinois Department of Financial and Professional Regulation’s license dataset also lists “Reprimand” dated May 15, 2018, case 2017002897 on nonresident license 054016601. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Pacifico National Inc.; Amex Pharmacy
- Location
- Melbourne, FL
- Type as FDA labels it
- 503A
- FDA’s note
- De-registered as an Outsourcing Facility
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Mar 10, 2021
- FDA Data Dashboard inspections
- 2 inspections: 1 VAI, 1 NAI; 2 published Form 483s
- State board records
- License found: PH16954, Closed; PH27532, Closed
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Pacifico National Inc., (dba Amex Pharmacy), a 503A facility, with 8 dated actions.
| Document | |||
|---|---|---|---|
| Mar 10, 2021 | State referral letter | Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021 | FDA copy (archived) |
| Mar 10, 2021 | FMD-145 letter | FMD-145 Letter Issued 03/10/2021 | Not linked by FDA |
| May 28, 2020 | FMD-145 letter | FMD-145 Letter Issued 05/28/2020 | FDA copy (archived) |
| Aug 30, 2019 | Recall notice | Firm Press Release: Pacifico National, Inc. dba AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab (08/30/2019) | FDA copy (archived) |
| Aug 30, 2019 | Recall notice | FDA Press Release: FDA Requests Recall of Sterile Compounded Drug Products Produced by Pacifico National Inc., dba AmEx Pharmacy, Reminds Patients and Health Care Professionals to Stop Using Due to Potential Risks (08/30/2019) | FDA copy (archived) |
| Aug 23, 2019 | Recall notice | Recall Letter Issued 08/23/2019 | FDA copy (archived) |
| Jun 28, 2019 | Press release or statement | FDA Statement : FDA Warns Patients and Health Care Professionals not to Use Sterile Products from Pacifico National Inc., dba AmEx Pharmacy (06/28/2019) | FDA copy (archived) |
| Jun 20, 2019 | Amended Form 483 | Amended 483 Issued 06/20/2019 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Pacifico National, Inc., Melbourne, FL (FEI number 3012034698), matched to this page by exact name, city and state. It lists 2 inspections: 1 VAI, 1 NAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| May 31, 2019 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3012034698 | 1091321 |
| Jan 21, 2016 | No Action Indicated (NAI) | Drug Quality Assurance (Drugs) | 3012034698 | 957266 |
Form 483s FDA has published for this site
- May 31, 2019: Form 483 to Pacifico National, Inc., published Jul 9, 2019. fda.gov
- Mar 4, 2016: Form 483 to Pacifico National, Inc., published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 2 Form 483 PDFs for Amex Pharmacy (Pacifico National Inc.), but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Jun 20, 2019: FDA document 128709: its numbered observations could not be read reliably from the PDF text.
- Mar 4, 2016: FDA document 96677: its numbered observations could not be read reliably from the PDF text.
State board of pharmacy records
The Florida Board of Pharmacy file dated Nov 15, 2026 lists these licenses under the same name, city and state as this pharmacy. Board file.
| License | Type as the board gives it | Name on the board record | City | Status |
|---|---|---|---|---|
| PH16954 | Pharmacy | PACIFICO NATIONAL, INC (dba AMEX PHARMACY) | MELBOURNE | Closed |
| PH27532 | Pharmacy | PACIFICO NATIONAL INC (dba Amex Pharmacy) | MELBOURNE | Closed |
Board actions
As the board words them, newest first. An entry that is a complaint, charge or notice the board filed is a charge, not a final decision; only an order or final action records the outcome.
- Feb 22, 2017: “Probation Satisfied”, license PH27532, case 201506647, PACIFICO NATIONAL INC, MELBOURNE, FL. Board list
- Mar 21, 2016: “Administrative Complaint Filed”, license PH27532, case 201506647, PACIFICO NATIONAL INC, MELBOURNE, FL. Board list
What this covers: Every enforcement action the Florida Department of Health lists for Board of Pharmacy pharmacy permits, worded as the department gives it. The list includes administrative complaints filed as well as final actions, and links no documents. An administrative complaint is an allegation the department has filed, not a finding. Actions in the data are dated Sep 19, 1980 to Nov 10, 2026.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| OSP 5907 | OSP | Pacifico National Inc | Melbourne, FL | Expired |
- Jun 29, 2021: “CLS Letter of Admonition”, license OSP 5907, case 2021-1448, Pacifico National Inc, Melbourne, FL. Board document
- Apr 22, 2021: “CLS Letter of Admonition”, license OSP 5907, case 2021-5, Pacifico National Inc, Melbourne, FL. Board document
- Jun 16, 2020: “CLS Stipulation”, license OSP 5907, case 2020-1439, Pacifico National Inc, Melbourne, FL. Board document
- Feb 25, 2020: “CLS Stipulation”, license OSP 5907, case 2019-6862, Pacifico National Inc, Melbourne, FL. Board document
- Apr 4, 2019: “CLS Letter of Admonition”, license OSP 5907, case 2018-9459, Pacifico National Inc, Melbourne, FL. Board document
- Oct 17, 2016: “CLS Stipulation”, license OSP 5907, case 2016-1288, Pacifico National Inc, Melbourne, FL. Board document
- Mar 30, 2016: “ITRM Cessation of Practice”, license OSP 5907, case 2016-1288, Pacifico National Inc, Melbourne, FL. Board document
Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 054016601 | LICENSED PHARMACY | PACIFICO NATIONAL INC (dba AMEX PHARMACY) | MELBOURNE, FL | CLOSED |
- May 15, 2018: “Reprimand”, license 054016601, case 2017002897, PACIFICO NATIONAL INC, MELBOURNE, FL. Reason given in the record: “due to an adverse action taken against its pharmacy license in the state of Florida.” Board list
Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| PCN.0003497 | NONRESIDENT PHARMACY | PACIFICO NATIONAL INC (dba AMEX PHARMACY) | MELBOURNE, FL | INACTIVE |
Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| A9-0001042 | Non Resident Pharmacy | Pacifico National, Inc. d/b/a/ Amex Pharmacy | MELBOURNE, FL | Closed |
| AA-0000029 | Outsourcing Facility-Pharmacy | Pacifico National, Inc. d/b/a/ Amex Pharmacy | MELBOURNE, FL | Expired |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- Florida Board of Pharmacy license file
- Colorado State Board of Pharmacy license file
- Illinois Department of Financial and Professional Regulation license file
- Connecticut Department of Consumer Protection license file
- Delaware Division of Professional Regulation license file
- Florida Board of Pharmacy disciplinary records
- Delaware Division of Professional Regulation disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.